A replication-competent smallpox vaccine LC16m8Δ-based COVID-19 vaccine

Viral vectors are a potent vaccine platform for inducing humoral and T-cell immune responses. Among the various viral vectors, replication-competent ones are less commonly used for coronavirus disease 2019 (COVID-19) vaccine development compared with replication-deficient ones. Here, we show the ava...

Descripción completa

Detalles Bibliográficos
Autores principales: Sakamoto, Akihiko, Osawa, Hiroaki, Hashimoto, Hinata, Mizuno, Tetsushi, Hasyim, Ammar A., Abe, Yu-ichi, Okahashi, Yuto, Ogawa, Ryohei, Iyori, Mitsuhiro, Shida, Hisatoshi, Yoshida, Shigeto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Coronaviruses
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9527789/
https://www.ncbi.nlm.nih.gov/pubmed/36069348
http://dx.doi.org/10.1080/22221751.2022.2122580

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9527789/
https://www.ncbi.nlm.nih.gov/pubmed/36069348
http://dx.doi.org/10.1080/22221751.2022.2122580

Ejemplares similares